Suppr超能文献

叶酸与乳腺癌风险:一项荟萃分析。

Folate and risk of breast cancer: a meta-analysis.

作者信息

Larsson Susanna C, Giovannucci Edward, Wolk Alicja

机构信息

Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, PO Box 210, SE-171 77 Stockholm, Sweden.

出版信息

J Natl Cancer Inst. 2007 Jan 3;99(1):64-76. doi: 10.1093/jnci/djk006.

Abstract

BACKGROUND

Epidemiologic findings are inconsistent concerning risk for breast cancer associated with low folate intake or blood folate levels. We performed a meta-analysis of prospective and case-control studies to examine folate intake and levels in relation to risk of breast cancer.

METHODS

We searched MEDLINE for studies of this association that were published in any language from January 1, 1966, through November 1, 2006. Study-specific risk estimates were pooled by use of a random-effects model. All statistical tests were two-sided.

RESULTS

Folate intake in increments of 200 microg/day was not associated with the risk of breast cancer in prospective studies (estimated summary relative risk [RR] = 0.97, 95% confidence interval [CI] = 0.88 to 1.07, for dietary folate [eight studies; 302,959 participants and 8367 patients with breast cancer], and RR = 1.01, 95% CI = 0.97 to 1.05, for total folate [six studies; 306,209 participants and 8165 patients with breast cancer]) but was statistically significantly inversely associated with risk in case-control studies (estimated summary odds ratio [OR] = 0.80, 95% CI = 0.72 to 0.89, for dietary folate [13 studies; 8558 case patients and 10,812 control subjects], and OR = 0.93, 95% CI = 0.81 to 1.07, for total folate [three studies; 2184 case patients and 3233 control subjects]). High blood folate levels versus low levels were not statistically significantly associated with the risk of breast cancer in prospective studies (OR = 0.81, 95% CI = 0.59 to 1.10 [three studies]) or in case-control studies (OR = 0.41, 95% CI = 0.15 to 1.10 [two studies]). Among the two prospective studies and two case-control studies that stratified by alcohol consumption, high folate intake (comparing the highest with the lowest category) was associated with a statistically significant decreased risk of breast cancer among women with moderate or high alcohol consumption (summary estimate = 0.51, 95% CI = 0.41 to 0.63) but not among women with low or no alcohol consumption (summary estimate = 0.95, 95% CI = 0.78 to 1.15). Few studies examined whether the relation between folate intake and breast cancer was modified by intakes of methionine or vitamins B6 and B12, and the findings were inconsistent.

CONCLUSION

No clear support for an overall relationship between folate intake or blood folate levels and breast cancer risk was found. Adequate folate intake may reduce the increased risk of breast cancer that has been associated with moderate or high alcohol consumption.

摘要

背景

关于低叶酸摄入量或血液叶酸水平与乳腺癌风险之间的关联,流行病学研究结果并不一致。我们进行了一项前瞻性研究和病例对照研究的荟萃分析,以探讨叶酸摄入量和水平与乳腺癌风险的关系。

方法

我们检索了MEDLINE数据库,查找1966年1月1日至2006年11月1日期间以任何语言发表的有关该关联的研究。采用随机效应模型汇总各研究的风险估计值。所有统计检验均为双侧检验。

结果

在前瞻性研究中,叶酸摄入量每增加200微克/天与乳腺癌风险无关(膳食叶酸的估计汇总相对风险[RR]=0.97,95%置信区间[CI]=0.88至1.07,八项研究;302,959名参与者和8367例乳腺癌患者,总叶酸的RR=1.01,95%CI=0.97至1.05,六项研究;306,209名参与者和8165例乳腺癌患者),但在病例对照研究中与风险呈统计学显著负相关(膳食叶酸的估计汇总比值比[OR]=0.80,95%CI=0.72至0.89,13项研究;8558例病例患者和10,812名对照受试者,总叶酸的OR=0.93,95%CI=0.81至1.07,三项研究;2184例病例患者和3233名对照受试者)。在前瞻性研究(OR=0.81,95%CI=0.59至1.10[三项研究])或病例对照研究(OR=0.41,95%CI=0.15至1.10[两项研究])中,高血液叶酸水平与低水平相比,与乳腺癌风险无统计学显著关联。在两项按饮酒量分层的前瞻性研究和两项病例对照研究中,高叶酸摄入量(最高类别与最低类别相比)与中度或高度饮酒女性的乳腺癌风险显著降低相关(汇总估计值=0.51,95%CI=0.41至0.63),但与低度或不饮酒女性无关(汇总估计值=0.95,95%CI=0.78至1.15)。很少有研究探讨叶酸摄入量与乳腺癌之间的关系是否因蛋氨酸、维生素B6和B12的摄入量而改变,且研究结果不一致。

结论

未发现叶酸摄入量或血液叶酸水平与乳腺癌风险之间存在明确的总体关系。充足的叶酸摄入量可能会降低与中度或高度饮酒相关的乳腺癌风险增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验